Thrasivoulos Karydis

Thrasivoulos Karydis is the founder of Deepure, a biotechnology company that aims to develop new pharmaceuticals using artificial intelligence to combat autoimmune and autoinflammatory diseases. The company has raised over $70 million since its inception to further its research and development efforts.